Hot Features
Premium
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Zeitraum:
Zeichenmodus:
| Volumen | 43.816 |
|
|||||
| News | - | ||||||
| Tageshoch | 1,08 | Niedrig Hoch |
|||||
| Tagestief | 1,01 | ||||||
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| Oragenics Inc | OGEN | AMEX | Common Stock |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| 0,00 | 0,00% | 1,06 | 02:00:00 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 1,07 | 1,01 | 1,08 | 1,03 | 1,06 |
| Trades | Volumen | VWAP | Finanzielles Volumen | Durchsch. Volumen | 52 Week Range |
|---|---|---|---|---|---|
| 357 | 43.816 | US$ 1,05 | US$ 45.828 | - | 1,01 - 7,74 |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| 02:00:00 | 100 | US$ 1,03 | USD |
Finanzwerte OGEN
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 0 | 2,57M | - | 38k | -20,66M | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Oragenics
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 19.4.2024 | 23:50 | Business Wire | Oragenics, Inc. Announces Notification of Noncompliance with.. |
| 01.4.2024 | 15:05 | Business Wire | Oragenics, Inc. Files 10K and Provides Company Update |
| 18.3.2024 | 12:00 | Business Wire | Oragenics Appoints James Kelly MD, Chief Medical Officer, to.. |
| 06.3.2024 | 22:24 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial.. |
| 05.3.2024 | 13:45 | Business Wire | Oragenics, Inc. Prepares Drug for Phase II Clinical Trials.. |
| 01.3.2024 | 22:04 | Business Wire | Oragenics Announces Closing of Public Offering |
| 29.2.2024 | 22:41 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 28.2.2024 | 15:03 | Edgar (US Regulatory) | Form 8-K - Current report |
| 28.2.2024 | 03:25 | Business Wire | Oragenics Announces Pricing of Public Offering |
| 27.2.2024 | 23:09 | Edgar (US Regulatory) | Form FWP - Filing under Securities Act Rules 163/433 of free.. |
| 27.2.2024 | 23:04 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 27.2.2024 | 22:33 | Business Wire | Oragenics Announces Proposed Public Offering |
Forum Oragenics
Keine Diskussionen Gefunden.Neuen Thread Erstellen
OGEN Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 1,16 | 1,22 | 1,01 | 1,08 | 23.975 | -0,10 | -8,62% |
| 1 Monat | 1,43 | 1,49 | 1,01 | 1,20 | 59.945 | -0,37 | -25,87% |
| 3 Monate | 2,42 | 4,00 | 1,01 | 1,68 | 95.054 | -1,36 | -56,20% |
| 6 Monate | 3,40 | 7,74 | 1,01 | 2,10 | 54.934 | -2,34 | -68,82% |
| 1 Jahr | 3,00 | 7,74 | 1,01 | 2,35 | 34.716 | -1,94 | -64,67% |
| 3 Jahre | 51,108 | 69,00 | 1,01 | 37,96 | 1.168.535 | -50,05 | -97,93% |
| 5 Jahre | 37,20 | 127,20 | 1,01 | 49,57 | 3.079.318 | -36,14 | -97,15% |
